Equities Analysts Offer Predictions for BIOX FY2026 Earnings

Key Points

• Analysts at Brookline Capital Management have revised their FY2026 earnings per share estimate for Bioceres Crop Solutions from $0.21 to ($0.12), maintaining a "Hold" rating on the stock.
• The consensus for Bioceres' current full-year earnings now stands at ($0.05) per share, following recent adjustments from several other analysts.
• Shares of Bioceres currently trading at $2.09 have seen significant fluctuations, with a 12-month low of $1.97 and a high of $8.93.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Stock analysts at Brookline Capital Management decreased their FY2026 earnings per share (EPS) estimates for shares of Bioceres Crop Solutions in a note issued to investors on Tuesday, September 9th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings of ($0.12) per share for the year, down from their prior forecast of $0.21. Brookline Capital Management currently has a "Hold" rating on the stock. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share.

A number of other brokerages have also recently issued reports on BIOX. Lake Street Capital reduced their price objective on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a "buy" rating for the company in a research note on Wednesday, September 10th. Oppenheimer set a $5.00 target price on shares of Bioceres Crop Solutions in a report on Tuesday, September 9th. Canaccord Genuity Group reissued a "hold" rating and set a $2.50 price target (down from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday, September 10th. Finally, Wall Street Zen downgraded Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a research report on Saturday. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $4.17.

Bioceres Crop Solutions Stock Down 4.4%

NASDAQ BIOX traded down $0.09 on Friday, reaching $1.95. 732,740 shares of the stock were exchanged, compared to its average volume of 544,544. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. Bioceres Crop Solutions has a one year low of $1.94 and a one year high of $8.78. The company's 50-day simple moving average is $3.26 and its two-hundred day simple moving average is $4.08.

Institutional Investors Weigh In On Bioceres Crop Solutions

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp lifted its stake in shares of Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after purchasing an additional 5,339 shares during the last quarter. Bank of America Corp DE raised its holdings in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after buying an additional 3,735 shares during the period. Northern Trust Corp purchased a new stake in Bioceres Crop Solutions during the 4th quarter valued at $93,000. Avanza Fonder AB bought a new stake in Bioceres Crop Solutions in the first quarter worth $72,000. Finally, PDT Partners LLC purchased a new position in Bioceres Crop Solutions during the first quarter worth $81,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.